Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (2185) Financial Statements

0 Followers

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H Financial Overview

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H's market cap is currently HK$851.96M. The company's EPS TTM is HK$-0.29; its P/E ratio is -7.27; Shanghai Bio-Heart Biological Technology Co., Ltd. Class H is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 43.77M	¥ 0.00	¥ 0.00	¥ 0.00	¥ 0.00
Gross Profit	¥ -157.81K	¥ 0.00	¥ -23.60M	¥ -24.25M	¥ 0.00
Operating Income	¥ -69.84M	¥ -61.04M	¥ -164.62M	¥ -293.28M	¥ -409.65M
EBITDA	¥ -52.13M	¥ -44.54M	¥ -148.21M	¥ -237.34M	¥ -400.88M
Net Income	¥ -68.24M	¥ -87.94M	¥ -194.36M	¥ -237.50M	¥ -361.45M
Balance Sheet
Cash & Short-Term Investments	¥ 248.63M	¥ 202.39M	¥ 369.44M	¥ 451.32M	¥ 708.53M
Total Assets	¥ 832.83M	¥ 733.78M	¥ 817.90M	¥ 981.52M	¥ 1.11B
Total Debt	¥ 12.73M	¥ 8.28M	¥ 1.76M	¥ 18.11M	¥ 22.45M
Net Debt	¥ -79.59M	¥ -194.10M	¥ -367.68M	¥ -486.39M	¥ -839.26M
Total Liabilities	¥ 220.47M	¥ 53.24M	¥ 44.04M	¥ 66.47M	¥ 80.04M
Stockholders' Equity	¥ 435.00M	¥ 660.47M	¥ 748.41M	¥ 883.21M	¥ 995.69M
Cash Flow
Free Cash Flow	¥ -72.91M	¥ -166.69M	¥ -66.74M	¥ -170.65M	¥ -147.28M
Operating Cash Flow	¥ -65.48M	¥ -119.55M	¥ -49.03M	¥ -140.62M	¥ -105.45M
Investing Cash Flow	¥ -39.78M	¥ -46.03M	¥ -28.86M	¥ -100.69M	¥ -33.73M
Financing Cash Flow	¥ -1.74M	¥ -2.44M	¥ -5.82M	¥ -35.18M	¥ 383.68M

Currency in CNY

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H Earnings and Revenue History

Income Statement >

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H Debt to Assets

Balance Sheet >

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H Cash Flow

Cash Flow >

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H Forecast EPS vs Actual EPS

Earnings >